PCCA, a leading FDA-registered supplier of active pharmaceutical ingredients, excipients and consulting for the compounding industry, today announced Gus Bassani, PharmD, will become chief executive ...

A plant-based compound called sulfuretin is being explored as a potential cancer treatment. Sulfuretin stopped the progression of cancer cells in a lab study. Researchers are doing additional ...

A formulation of 1-mg/mL oral suspension was prepared from commercially available 20-mg lisinopril tablets, using Bicitra and Ora-Sweet SF as the compounding vehicles to make a final volume of 200 mL.

Current U.S. regulations permit compounding pharmacies to replicate medications experiencing short supply, providing options for those unable to afford brand-name alternatives.